Literature DB >> 15265277

The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease.

Thomasina L Bailey1, Claire B Rivara, Anne B Rocher, Patrick R Hof.   

Abstract

Age-related and amyloid-induced pathology of the cerebral microvasculature have been implicated as potential contributing factors to the pathogenesis of Alzheimer's disease (AD). The microvasculature plays a crucial role in maintaining brain homeostasis and deterioration of its integrity may have deleterious effects on brain function in AD, possibly leading to neurofibrillary degeneration, plaque formation, and cell loss. Brain vessels possess peculiar anatomical and physiological properties owing to their role in the exchange processes of various substances between blood and brain, which are highly regulated for the maintenance of ionic homeostasis of the neuronal environment. Here we review neuropathological aspects of cortical microvessels in aging and AD in relationship to known cardiovascular risk factors and their possible impact on the cognitive decline seen in late-onset dementia.

Entities:  

Mesh:

Year:  2004        PMID: 15265277     DOI: 10.1179/016164104225016272

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  82 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells.

Authors:  Huan Du; Pengtao Li; Jun Wang; Xuemei Qing; Weihong Li
Journal:  Cell Mol Neurobiol       Date:  2011-08-12       Impact factor: 5.046

Review 3.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

4.  Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins.

Authors:  Hsin-Kai Liao; Ying Wang; Kristin E Noack Watt; Qin Wen; Justin Breitbach; Chelsy K Kemmet; Karl J Clark; Stephen C Ekker; Jeffrey J Essner; Maura McGrail
Journal:  Dev Dyn       Date:  2012-02       Impact factor: 3.780

5.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

Review 6.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

Review 7.  Neuropathology in the adult changes in thought study: a review.

Authors:  Joshua A Sonnen; Eric B Larson; Sebastien Haneuse; Randy Woltjer; Ge Li; Paul K Crane; Suzanne Craft; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 9.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 10.  Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.

Authors:  Juan M Zolezzi; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.